참고문헌
- Oncogene v.13 Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas Bhatia,K.;A.Raj;M.I.Guitierrez;J.G.Judde;G.Spangler;H.Venkatesh;I.T.Magrath
- J. Microbiol. v.36 Sequence analysis of the latent membrane protein 1 genes of Epstein-Barr virus isolates in Korea Cho,S.;S.G.Cho;Y.S.Shim;W.K.Lee
- J. Microbiol. Biotechnol. v.10 Analysis of genetic polymorphisms of Epstein-Barr virus isolates from cancer patients and healthy carriers Cho,S.G.;W.K.Lee
- Mol. Cell. Biol. v.16 Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation Devergne,O.;E.Hatzivassiliou;K.M.Izumi;K.M.Kaye;M.F.Kleijnen;E.Kieff;G.Mosialos
- Virology v.261 Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains Edwards,R.H.;F.Seillier- Moiseiwitsch;N.Raab- Traub https://doi.org/10.1006/viro.1999.9855
- J. Biol. Chem. v.274 Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production Eliopoulos,A.G.;N.J.Gallagher;S.M.Blake;C.W.Dawson;L.S.Young https://doi.org/10.1074/jbc.274.23.16085
- Oncogene v.16 Activation of the cJun Nterminal kinase (JNK) pathway by the Epstein- Barr virusencoded latent membrane protein 1 (LMP1) Eliopoulos,A.G.;L.S.Young https://doi.org/10.1038/sj.onc.1201694
- Semin. Cancer Biol. v.11 LMP1 structure and signal transduction. Eliopoulos,A.G.;L.S.Young https://doi.org/10.1006/scbi.2001.0410
- J. Gen. Virol. v.76 The role of repetitive DNA sequences in the size variation of Epstein- Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis Falk,K.;J.W.Gratama;M.Rowe;J.Z.Zou;F.Khanim;L.S.Young;M.A.Oosterveer;I.Ernberg https://doi.org/10.1099/0022-1317-76-4-779
- EMBO J. v.18 Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins Gires,O.;F.Kohlhuber;E.Kilger;M.Baumann;A.Kieser;C.Kaiser;R.Zeidler;B.Scheffer;M.Ueffing;W.Hammerschmidt https://doi.org/10.1093/emboj/18.11.3064
- J. Virol. v.76 The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines Higuchi,M.;E.Kieff;K.M.Izumi https://doi.org/10.1128/JVI.76.1.455-459.2002
- J. Gen. Virol. v.72 Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma Hu,L.F.;E.R.Zabarovsky;F.Chen;S.L.Cao;I.Ernberg;G.Klein;G.Winberg https://doi.org/10.1099/0022-1317-72-10-2399
- Oncogene v.10 The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain Huen,D.S.;S.A.Henderson;D.Croom- Carter;M.Rowe
- J. Virol. v.73 The residues between the two transformation effector sites of Epstein- Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation Izumi,K.M.;E.D.Cahir;McFarland;E.A.Riley;D.Rizzo;Y.Chen;E.Kieff
- Mol. Cell. Biol. v.19 The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation Izumi,K.M.;E.D.Cahir McFarland;A.T.Ting;E.A.Riley;B.Seed;E.D.Kieff
- Proc. Natl. Acad. Sci. USA v.90 Epstein-Barr virus latent membrane protein 1 is essential for B- lymphocyte growth transformation Kaye,K.M.;K.M.Izumi;E.Kieff https://doi.org/10.1073/pnas.90.19.9150
- Proc. Natl. Acad. Sci. USA v.95 Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice Kulwichit,W.;R.H.Edwards;E.M.Davenport;J.F.Baskar;B.Godfrey;N.Raab Traub https://doi.org/10.1073/pnas.95.20.11963
- J. Biol. Chem. v.267 The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B Laherty,C.D.;H.M. Hu;A.W.Opipari;F.Wang;V.M.Dixit
- Vitro Cell. Dev. Biol.: Animal v.34 Characterization of B-lymphoblastoid cell lines established from Korean cancer patients Lee,W.K.;S.M.Kim;Y.S.Shim;S.G.Cho;S.H.Park;C.W.Kim;J.G.Park https://doi.org/10.1007/s11626-998-0090-1
- J. Gen. Virol. v.75 Sequence variation in the Epstein-Barr virus latent membrane protein 1 Miller,W.E.;R.H.Edwards;D.M.walling;N.Raab-Traub https://doi.org/10.1099/0022-1317-75-10-2729
- J. Virol. v.71 Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF- kappaB activation Miller,W.E.;G.Mosialos;E.Kieff;N.Raab-Traub
- Virology v.192 Strain variation in Epstein-Barr virus immediate early genes Packham,G.;M.Brimmell;D.Cook;A.J.Sinclair;P.J.Farrell https://doi.org/10.1006/viro.1993.1070
- J. Virol. v.64 Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes Sample,J.;L.Young;B.Martin;T.Chatman;E.Kieff;A.Rickinson
- Blood v.90 Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates Sandvej,K.;J.W.Gratama;M.Munch;X.G.Zhou;R.L.Bolhuis;B.S.Andresen;N.Gregersen;S.Hamilton-Dutoit
- Mol. Cells v.8 Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea Shim,Y.S.;C.W.Kim;W.K.Lee
- Int. J. Cancer v.76 Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China Sung,N.S.;R.H.Edwards;F.Seillier-Moiseiwitsch;A.G.Perkins;Y.Zeng;N.Raab Traub https://doi.org/10.1002/(SICI)1097-0215(19980413)76:2<207::AID-IJC7>3.0.CO;2-0
- Cell v.43 An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Wang,D.;D.Liebowitz;E.Kieff https://doi.org/10.1016/0092-8674(85)90256-9
- J. Virol. v.64 Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 Wang,F.;C.Gregory;C.Sample;M.Rowe;D.Liebowitz;R.Murray;A.Rickinson;E.Kieff